| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility
|
Yang, Guohze
|
|
2004
|
6 |
2 |
p. 139-150
12 p.
|
article
|
| 2 |
Focus on bladder cancer
|
Dinney, Colin P.N.
|
|
2004
|
6 |
2 |
p. 111-116
6 p.
|
article
|
| 3 |
Hepsin promotes prostate cancer progression and metastasis
|
Klezovitch, Olga
|
|
2004
|
6 |
2 |
p. 185-195
11 p.
|
article
|
| 4 |
Mining our ABCs
|
Ross, Douglas D.
|
|
2004
|
6 |
2 |
p. 105-107
3 p.
|
article
|
| 5 |
Predicting drug sensitivity and resistance
|
Szakács, Gergely
|
|
2004
|
6 |
2 |
p. 129-137
9 p.
|
article
|
| 6 |
Preferential response of cancer cells to zebularine
|
Cheng, Jonathan C.
|
|
2004
|
6 |
2 |
p. 151-158
8 p.
|
article
|
| 7 |
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|
Nagata, Yoichi
|
|
2004
|
6 |
2 |
p. 117-127
11 p.
|
article
|
| 8 |
Species- and cell type-specific requirements for cellular transformation
|
Rangarajan, Annapoorni
|
|
2004
|
6 |
2 |
p. 171-183
13 p.
|
article
|
| 9 |
SRCircumventing imatinib resistance
|
Deininger, Michael W.N.
|
|
2004
|
6 |
2 |
p. 108-110
3 p.
|
article
|
| 10 |
Successful targeting of ErbB2 receptors—is PTEN the key?
|
Crowder, Robert J.
|
|
2004
|
6 |
2 |
p. 103-104
2 p.
|
article
|
| 11 |
Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction
|
White, Donald E.
|
|
2004
|
6 |
2 |
p. 159-170
12 p.
|
article
|
| 12 |
Toward a functional taxonomy of cancer
|
Golub, Todd R.
|
|
2004
|
6 |
2 |
p. 107-108
2 p.
|
article
|
Journal description